Biofrontera Inc. Business Combination, Contingent Consideration, Liability
Biofrontera Inc. (BFRI) had Business Combination, Contingent Consideration, Liability of $9.71 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2023-11-09
- 2023-09-30: Business Combination, Contingent Consideration, Liability $9.71M.
- 2023-06-30: Business Combination, Contingent Consideration, Liability $9.42M.
- 2023-03-31: Business Combination, Contingent Consideration, Liability $9.23M.
- 2022-12-31: Business Combination, Contingent Consideration, Liability $9.34M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2023-09-30 | $9.71M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $9.42M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $9.23M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $9.34M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $8.95M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $12.78M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |